Catalyst Health & Technology Partners

Catalyst Health Ventures (CHV), formerly known as Catalyst Health & Technology Partners, is a Boston-based venture capital firm specializing in early-stage investments within the healthcare sector. Founded in 1998, the firm focuses on medical devices, diagnostics, and life science tools that address significant unmet clinical needs and provide demonstrable value to the healthcare system. CHV is known for its hands-on investment approach, often leading or co-leading rounds and providing strategic guidance through board representation. Its portfolio includes successful exits such as Augmenix, Hansen Medical, and Novazyme, as well as active companies like Conformal Medical and Brixton Biosciences. The firm's investment strategy emphasizes technologies with clear clinical benefits and strong economic value propositions for patients, providers, and payers.